Acotec Scientific Holdings Limited (HK:6669) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Acotec Scientific Holdings Limited has gained approval from the PRC National Medical Products Administration for its Delivery Catheter designed for the AcoStream® aspiration catheter, enhancing its use in peripheral vascular procedures. This development marks a significant step for Acotec’s product portfolio, potentially boosting its market presence in China. Investors are advised to approach with caution as marketing plans are still under consideration.
For further insights into HK:6669 stock, check out TipRanks’ Stock Analysis page.